Michael Narachi
Director · 1 filing · Latest: May 14, 2026
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RARE | Michael Narachi | Director | May 14, 2026 | Grant/Award | $0.00 | 7,751 | — | 40,441 |